Hosted on MSN

USD 5.5 billion deal: Biocon to merge biologics unit; to acquire stake held by Serum, Mylan

USD 5.5 billion deal: Biocon, an innovation-driven global biopharmaceuticals company, on Saturday, December 6 2025, announced a strategic move to fully integrate Biocon Biologics Limited (BBL) as a ...
Hosted on MSN

Biocon to merge biologics arm in $5.5 billion deal

Biocon will fully integrate its biosimilars arm, Biocon Biologics into the parent, in a deal valuing the unit at $5.5 billion. The move is aimed at creating a unified biopharma powerhouse, and to ...